CN

Carina Namih

Founder of HelixNano

London, England

Overview

Work Experience

P

Plural

  • Partner

    2022 - Current

    Plural is an early-stage investment fund that backs the most ambitious founders on a mission to change the world through technology. Our aim is to have GDP-level impact on Europe, address systemic risks and reduce the opportunity gap worldwide through the companies we back.

H

HelixNano

  • Co-Founder, Board Member and former CEO

    2013

    HelixNano is an AI driven biotech developing next generation mRNA therapies.

RA

Robin AI

  • Board Member

    2021

SG

Sano Genetics

  • Board Member

    2020 - 2022

O

Omnipresent

  • Board Member

    2020 - 2022

P

Phasecraft

  • Board Member

    2020 - 2022

M

MediShout

  • Board Member

    2019 - 2022

A

Auquan

  • Board Member

    2019 - 2022

E1

Episode 1 Ventures

  • General Partner

    2018 - 2022

Education

Investments

Sano Genetics

Series A

Total Funding: $23M

Robin AI

Series B

Total Funding: $43M

Omnipresent

Seed

Total Funding: $140M

MediShout

Seed

Total Funding: $2M

Relevant Websites